Applying the principles of stem-cell biology to cancer

Why are tumours heterogeneous, in terms of cell phenotype and proliferative potential, even in cases in which all cells are derived from a single clone? Ongoing mutagenesis can partially explain this heterogeneity, but it also seems that some tumours arise from small populations of 'cancer stem cells' that give rise to phenotypically diverse cancer cells, with less proliferative potential. These cancer stem cells are likely to arise from mutations that dysregulate normal stem-cell self-renewal. Using this information, it might be possible to devise more effective therapies.

[1]  M. van Lohuizen,et al.  Polycomb repression: from cellular memory to cellular proliferation and cancer. , 2002, Biochimica et biophysica acta.

[2]  A. McMahon,et al.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. , 2001, Development.

[3]  M. Scott,et al.  Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.

[4]  I. Roninson,et al.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.

[5]  M. Scott,et al.  Control of Neuronal Precursor Proliferation in the Cerebellum by Sonic Hedgehog , 1999, Neuron.

[6]  Hans Clevers,et al.  The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells , 2002, Cell.

[7]  R. Paus,et al.  Sonic hedgehog signaling is essential for hair development , 1998, Current Biology.

[8]  A. Balmain,et al.  Stem-cell hierarchy in skin cancer , 2003, Nature Reviews Cancer.

[9]  D. Howard,et al.  Preferential induction of apoptosis for primary human leukemic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I. Bernstein,et al.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling , 2000, Nature Medicine.

[11]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[12]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[13]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.

[14]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[15]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[16]  W. R. Bruce,et al.  A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo , 1963, Nature.

[17]  D. Marlowe.  Progress and Puzzles. , 1967 .

[18]  D. Gilliland,et al.  Genetics of myeloid leukemias. , 2003, Annual review of genomics and human genetics.

[19]  I. Wodinsky,et al.  Spleen colony studies of leukemia L1210. VI. Quantitation of the surviving population of frozen-thawed L1210 cells using the spleen colony assay. , 1968, Cryobiology.

[20]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[21]  M. Sofroniew,et al.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.

[22]  L. Einhorn,et al.  Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Sauvageau,et al.  Stage-specific expression of polycomb group genes in human bone marrow cells. , 1998, Blood.

[24]  J. Gordon,et al.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.

[25]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[26]  S. Morrison.  Pten-uating neural growth , 2002, Nature Medicine.

[27]  Y. Haupt,et al.  bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. , 1993, Oncogene.

[28]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[29]  J. Rubin,et al.  Wnt signaling in B-cell neoplasia , 2003, Oncogene.

[30]  Su-Jae Lee,et al.  Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. , 2002, Blood.

[31]  T. Austin,et al.  A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. , 1997, Blood.

[32]  R. Dickson,et al.  Ultrastructure of the putative stem cell niche in rat mammary epithelium. , 2003, Tissue & cell.

[33]  G. B. Pierce,et al.  Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[34]  G. B. Pierce,et al.  Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. , 1988, Cancer research.

[35]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[36]  D. Gallahan,et al.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. , 1992, Genes & development.

[37]  D. Louis,et al.  PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.

[38]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[39]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[40]  C. Raffel,et al.  Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations , 1998 .

[41]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[42]  Xi He,et al.  Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism , 2002, Cell.

[43]  M. Scott,et al.  The developmental biology of brain tumors. , 2001, Annual review of neuroscience.

[44]  A. Trumpp,et al.  Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.

[45]  P. Lansdorp,et al.  Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. , 1997, Blood.

[46]  F. Watt,et al.  beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. , 1999, Development.

[47]  T Pietsch,et al.  Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. , 1997, Cancer research.

[48]  P. Sánchez,et al.  Gli and hedgehog in cancer: tumours, embryos and stem cells , 2002, Nature Reviews Cancer.

[49]  Elaine Fuchs,et al.  A common human skin tumour is caused by activating mutations in β-catenin , 1999, Nature Genetics.

[50]  Pierce Gb,et al.  Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. , 1988 .

[51]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[52]  W. Birchmeier,et al.  β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin , 2001, Cell.

[53]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[54]  A. Hamburger,et al.  Primary bioassay of human tumor stem cells. , 1977, Science.

[55]  D. Howard,et al.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells , 2000, Leukemia.

[56]  K. Trott,et al.  12 – Tumour stem cells , 1997 .

[57]  M. Pallis,et al.  P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. , 2000, Blood.

[58]  E. Campo,et al.  BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. , 2001, Cancer research.

[59]  H. Cui,et al.  Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells. , 1998, Brain research. Developmental brain research.

[60]  D. Alberts,et al.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. , 1978, The New England journal of medicine.

[61]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[62]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[64]  S. Nishiguchi,et al.  Polycomb Group Gene rae28 Is Required for Sustaining Activity of Hematopoietic Stem Cells , 2002, The Journal of experimental medicine.

[65]  A. Knudson,et al.  [Heredity and cancer in man]. , 1953, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[66]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[67]  E. Fuchs,et al.  De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin , 1998, Cell.

[68]  J. Dick,et al.  Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[70]  E. McCulloch.  Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). , 1983, Blood.

[71]  R. Willemze,et al.  The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma , 2001, British journal of haematology.

[72]  Pier Paolo Pandolfi,et al.  The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.

[73]  C. Meijer,et al.  Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. , 2001, Blood.

[74]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[75]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[76]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[77]  Kenneth Chu,et al.  Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC , 2002, Science.

[78]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[79]  E. McCulloch.  Stem Cells in Normal and Leukemic Hemopoiesis , 2005 .

[80]  D. J. Van Den Berg,et al.  Role of members of the Wnt gene family in human hematopoiesis. , 1998, Blood.

[81]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[82]  Olivier Pourquié,et al.  Maintenance of neuroepithelial progenitor cells by Delta–Notch signalling in the embryonic chick retina , 1997, Current Biology.

[83]  C. Wetmore,et al.  Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. , 2003, Current opinion in genetics & development.

[84]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[86]  L. Parada,et al.  The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.

[87]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[88]  Mark J Alkema,et al.  Perturbation of B and T cell development and predisposition to lymphomagenesis in EμBmi1 transgenic mice require the Bmi1 RING finger , 1997, Oncogene.

[89]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[90]  Anjen Chenn,et al.  Regulation of Cerebral Cortical Size by Control of Cell Cycle Exit in Neural Precursors , 2002, Science.

[91]  R. Moon,et al.  Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[92]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[93]  N. Dahmane,et al.  Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours , 1997, Nature.

[94]  R. Johnstone,et al.  P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. , 1999, Blood.

[95]  A. McMahon,et al.  Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. , 1997, Developmental biology.

[96]  W Gaffield,et al.  Essential role for Sonic hedgehog during hair follicle morphogenesis. , 1999, Developmental biology.

[97]  Fred H. Gage,et al.  Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo , 2003, Nature Neuroscience.

[98]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[99]  H. Nakauchi,et al.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.

[100]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[101]  Hans Clevers,et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.

[102]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[103]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[104]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[105]  K. Trott.  Tumour stem cells: the biological concept and its application in cancer treatment. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[106]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.